Related Experiment Video
Updated: Apr 3, 2026
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
1.3K
Idiopathic pulmonary fibrosis: moving forward
Luca Richeldi1,2,3
1University of Southampton, Southampton, UK. L.Richeldi@soton.ac.uk.
BMC Medicine
|September 25, 2015
Summary
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with increasing incidence. Early diagnosis and management are crucial, especially with new effective treatments now available for interstitial lung disease (ILD).
Area of Science:
- Pulmonology
- Respiratory Medicine
- Interstitial Lung Disease (ILD)
Background:
- Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease (ILD) with increasing global incidence.
- IPF is increasingly recognized as a significant unmet medical need in respiratory medicine.
- The prognosis of IPF is comparable to that of certain cancers, highlighting its severity.
Discussion:
- Intense research has led to significant advancements in understanding IPF.
- Two new safe and effective drugs for IPF are now available to patients.
- Accurate diagnosis of IPF is critical and no longer acceptable to miss.
Key Insights:
- Early identification and improved management of ILD, particularly IPF, are essential.
- Spreading knowledge about IPF across medical specialties is a global necessity.
- New therapeutic options offer improved patient outcomes.
Outlook:
- Continued research and global knowledge dissemination aim for better patient outcomes in IPF.
- Focus on early diagnosis and management strategies for interstitial lung diseases.
- Advancements in IPF treatment underscore the importance of timely medical intervention.
More Related Videos
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.1K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.1K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.1K
01:20COPD: Pathogenesis and Clinical Features
2.2K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K
01:30Pulmonary Hypertension: Classification and Pathogenesis
870
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
870
01:24Chronic Obstructive Pulmonary Disease
3.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.2K
01:29Pneumonia II: Pathophysiology
4.2K
The pathophysiology of pneumonia involves the following steps:
4.2K